Cable Hill Partners’s AbbVie ABBV Stock Holding History

Cable Hill Partners’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,000	Closed	-$92K	–	813
2018 Q4	$92K	Hold	1,000	–	–	0.04%	167
2018 Q3	$94K	Hold	1,000	–	–	0.04%	112
2018 Q2	$93K	Hold	1,000	–	–	0.04%	123
2018 Q1	$90K	Buy	+1,000	New	+$110K	0.04%	126

Other funds holding ABBV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Cable Hill Partners's ABBV Position: Q1 2025 in Review

Cable Hill Partners reduced its AbbVie (ABBV) stake by 31% in Q1 2025, selling an estimated $212K and leaving 2,447 shares worth $481K. The position accounts for 0.05% of the portfolio, ranked #92.

Cable Hill Partners first reported a position in ABBV in Q4 2014 and has held it in 40 quarters since. The position peaked at $1.13M in Q4 2022. 3,820 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

Cable Hill Partners held 2,447 shares of AbbVie worth $481K as of Q1 2025.
Cable Hill Partners sold 1,091 AbbVie shares in Q1 2025, an estimated $212K.
AbbVie made up 0.05% of Cable Hill Partners's portfolio in Q1 2025, its #92 holding.
Cable Hill Partners first reported a position in AbbVie in Q4 2014 and has held it in 40 quarters since.
Cable Hill Partners's AbbVie position peaked at $1.13M in Q4 2022.
3,820 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Cable Hill Partners's 13F filing for Q1 2025, filed 2 May 2025.